AstraZeneca’s Covid vaccine linked to another rare fatal blood clotting disorder
New Delhi: British-Swedish pharma giant AstraZeneca's Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but fatal blood clotting disorder, claimed researchers Thursday. While not new, VITT emerged as...







































